Back to Search
Start Over
Supplementary Figures from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....1bc4ca9a28232b9ab6dbed65a27587fa